Selector High Conviction Equity Fund

March 2026 Quarterly Newsletter

In this quarterly, we provide a collection of portfolio company commentaries following the February reporting season. We provide a deeper dive into sleep apnea leader Resmed in our article “Resmed - some facts”. We then consider why investors should pay closer attention to how companies arrive at the bottom line in “Apples and coconuts”. This is followed up with a closer look at three portfolio holdings: FINEOS Corporation Holdings, TechnologyOne and WiseTech Global.

This update has been prepared by Selector Funds Management Limited (“Selector”) ACN 102 856 347 AFSL 225316 to provide you with general information only. In preparing this update, we do not take into account your investment objectives, financial situation or particular needs. It is not intended to take the place of professional advice and you should not take action in reliance on this information. Neither Selector, or any of its related parties, their employees or directors, provide a warranty of accuracy or reliability for this information or accept any liability to any person who relies on it. Past performance is not an indicator of future performance. Selector does not guarantee the repayment of capital, payment of income or performance. Unauthorised use, copying, distribution, transmitting, publication, display, or reproduction in whole or in part of the information contained in this material is prohibited without prior written consent from Selector.

Unauthorised use, copying, distribution, transmitting, publication, display, or reproduction in whole or in part of the information contained in this material is prohibited without prior written consent from Selector.